Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Low Endotoxin
- SKU:
- IVMB0078
- Product Type:
- In Vivo Monoclonal Antibody
- Clone:
- IM7
- Protein:
- CD44
- Isotype:
- Rat IgG2b kappa
- Reactivity:
- Human
- Mouse
- Synonyms:
- Hermes
- Pgp-1
- H-CAM
- HUTCH-1
- ECMR III
- gp85
- Ly-24
- Research Area:
- Adhesion & Migration
- Endotoxin Level:
- Low Endotoxin
- Host Species:
- Rat
- Applications:
- CODEX
- CyTOF
- ELISA Det
- FC
- ICC
- IHC FF
- IHC FFPE
- IP
- WB
![Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Low Endotoxin](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/1280x1280/products/214413/569499/anti-mousehuman-cd44-im7-in-vivo-antibody-low-endotoxin__61349.1673497113.jpg?c=2&imbypass=on "Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Low Endotoxin")
Description
Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Low Endotoxin
Introducing the Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Low Endotoxin from Assay Genie, a highly specific monoclonal antibody meticulously designed for in vivo applications.
This antibody targets the CD44 protein, known for its pivotal role in cell-cell interactions, cell adhesion, and migration, making it essential for research in oncology, immunology, and cellular biology. With a rat IgG2b isotype, it guarantees high purity and low endotoxin levels (<0.1 EU/µg), making it suitable for applications such as flow cytometry, immunoprecipitation, and in vivo blocking studies. Available in various sizes, it is formulated in endotoxin-free phosphate buffer to ensure stability and efficacy. Elevate your research with this dependable and versatile antibody. CD44 is a cell surface glycoprotein involved in a wide array of cellular functions including lymphocyte activation, recirculation, homing, hematopoiesis, and tumor metastasis. It is widely expressed on a variety of cell types such as hematopoietic cells, fibroblasts, keratinocytes, and epithelial cells, highlighting its importance in both normal physiology and pathological conditions.
| Product Name: | Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Low Endotoxin |
| Product Code: | IVMB0078 |
| Size: | 1mg, 5mg, 25mg, 50mg, 100mg |
| Clone: | IM7 |
| Protein: | CD44 |
| Product Type: | Monoclonal Antibody |
| Synonyms: | Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24 |
| Isotype: | Rat IgG2b κ |
| Reactivity: | Human, Mouse |
| Immunogen: | Dexamethasone-induced myeloid leukemia M1 cells |
| Applications: | CyTOF®, ELISA Det, FC, ICC, IHC FF, IHC FFPE, IP, PhenoCycler®, WB |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | ≥95% monomer by analytical SEC >95% by SDS Page |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
| Applications: | CODEX®, CyTOF®, ELISA Det, FC, ICC, IHC FF, IHC FFPE, IP, WB |
| Recommended Usage: | FC The suggested concentration for this IM7 antibody for staining cells in flow cytometry is ≤ 0.25 µg per 106 in a volume of 100 µl or 100µl of whole blood. Titration of the reagent is recommended for optimal performance for each application. WB The suggested concentration for this P84 antibody for use in western blotting is 1-10 µg/ml. |
| Reactivity: | Human, Mouse |
| Host Species: | Rat |
| Specificity: | Clone IM7 recognizes an epitope common to alloantigens and all isoforms of CD44 that is located between amino acids 145 and 186. |
| Antigen Distribution: | CD44 is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells in addition to B-cells, monocytes, macrophages and certain subsets of thymocytes and peripheral T-cells. Mice with the Ly-24.1 allotype have high densities of CD44+ T-cells. |
| Immunogen: | Dexamethasone-induced myeloid leukemia M1 cells |
| Concentration: | ≥ 5.0 mg/ml |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | ≥95% monomer by analytical SEC >95% by SDS Page |
| Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
CD44 is an 80-95 kD glycoprotein that plays a role in various cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. CD44 interacts with osteopontin, collagens, and matrix metalloproteinases (MMPs) and is a receptor for hyaluronic acid. Transcripts for this gene go through intricate alternative splicing that result in a variety of functionally distinct isoforms, including those which may be related to tumor metastasis. These splice variants of CD44 function as receptors under hemodynamic flow conditions that are significant to the development of cancer metastasis. Hence, it is thought that anti-CD44 tumor-specific mAbs may have therapeutic potential. This therapeutic potential of anti-CD44 mAbs is evident in some animal experiments demonstrating a reduction in malignant activities of various neoplasms when CD44 was targeted by a combination of mAbs, antisense oligonucleotides, and CD44-soluble proteins. It has been reported that high levels of CD44 on leukemic cells fuel leukemia production. Notably, various cancer studies show conflicting results pertaining to level of CD44 expression and its correlation with disease prognosis. Before anti-CD44 therapy can be applied to human cancers, it is essential to resolve this inconsistency.
| Technical Datasheet: | View |
| Protein: | CD44 |
| Function: | Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM |
| Ligand/Receptor: | Hyaluronan, MIP-1β, fibronectin, collagen |
| Research Area: | Cell Adhesion, Cell Biology, Immunology, Stem Cell |
Meet the team!
Shane Costigan
Territory Manager & Team Lead
Abdul Khadim
Sales Executive
Related Products
![Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Ultra Low Endotoxin](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/214414/569448/anti-mousehuman-cd44-im7-in-vivo-antibody-ultra-low-endotoxin__90696.1673496896.jpg?c=2 "Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Ultra Low Endotoxin")
Anti-Mouse/Human CD44 [IM7] In Vivo Antibody - Ultra Low Endotoxin
Anti-Mouse CD19 In Vivo Antibody - Low Endotoxin
Anti-Mouse CD209b In Vivo Antibody - Low Endotoxin
Anti-Mouse CD25 In Vivo Antibody - Low Endotoxin
